These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28711499)

  • 1. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista.
    Shi W; Yan D; Zhao C; Xiao M; Wang Y; Ma H; Liu T; Qin H; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
    Biochem Biophys Res Commun; 2017 Sep; 491(1):159-165. PubMed ID: 28711499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE
    Luo P; Shi W; Wang Y; Ma H; Liu T; Yan D; Huo S; Guo J; Wang M; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    Life Sci; 2020 Nov; 261():118304. PubMed ID: 32828944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells.
    Kim DH; Park KW; Chae IG; Kundu J; Kim EH; Kundu JK; Chun KS
    Mol Carcinog; 2016 Jun; 55(6):1096-110. PubMed ID: 26152521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.
    Li H; Xiao H; Lin L; Jou D; Kumari V; Lin J; Li C
    J Med Chem; 2014 Feb; 57(3):632-41. PubMed ID: 24456369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 can be activated through paracrine signaling in breast epithelial cells.
    Lieblein JC; Ball S; Hutzen B; Sasser AK; Lin HJ; Huang TH; Hall BM; Lin J
    BMC Cancer; 2008 Oct; 8():302. PubMed ID: 18939993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picrasidine G decreases viability of MDA-MB 468 EGFR-overexpressing triple-negative breast cancer cells through inhibition of EGFR/STAT3 signaling pathway.
    Yamashita N; Kondo M; Zhao S; Li W; Koike K; Nemoto K; Kanno Y
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2608-2612. PubMed ID: 28427809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
    Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
    BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
    Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells.
    Zhao C; Wang W; Yu W; Jou D; Wang Y; Ma H; Xiao H; Qin H; Zhang C; Lü J; Li S; Li C; Lin J; Lin L
    Oncotarget; 2016 Mar; 7(11):12917-26. PubMed ID: 26883202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3.
    Wang W; Zhao C; Jou D; Lü J; Zhang C; Lin L; Lin J
    Anticancer Res; 2013 Oct; 33(10):4279-84. PubMed ID: 24122993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
    Xiao H; Bid HK; Chen X; Wu X; Wei J; Bian Y; Zhao C; Li H; Li C; Lin J
    PLoS One; 2017; 12(7):e0180297. PubMed ID: 28672024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
    Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST
    Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.
    Yang J; Qian S; Cai X; Lu W; Hu C; Sun X; Yang Y; Yu Q; Gao SP; Cao P
    Mol Cancer Ther; 2016 Jun; 15(6):1190-200. PubMed ID: 26929249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3.
    Shen A; Chen Y; Hong F; Lin J; Wei L; Hong Z; Sferra TJ; Peng J
    Oncol Rep; 2012 Dec; 28(6):2125-30. PubMed ID: 23027374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological Inhibition of CDK8 in Triple-Negative Breast Cancer Cell Line MDA-MB-468 Increases E2F1 Protein, Induces Phosphorylation of STAT3 and Apoptosis.
    Spear JM; Lu Z; Russu WA
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33291686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.